PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Common COVID-19 antibiotic no more effective than placebo

UCSF outpatient study found limited effect of azithromycin on progression of disease

2021-07-16
(Press-News.org) A UC San Francisco study has found that the antibiotic azithromycin was no more effective than a placebo in preventing symptoms of COVID-19 among non-hospitalized patients, and may increase their chance of hospitalization, despite widespread prescription of the antibiotic for the disease.

"These findings do not support the routine use of azithromycin for outpatient SARS-CoV-2 infection," said lead author Catherine E. Oldenburg, ScD, MPH, an assistant professor with the UCSF Proctor Foundation. SARS-CoV-2 is the virus that causes COVID-19.

Azithromycin, a broad-spectrum antibiotic, is widely prescribed as a treatment for COVID-19 in the United States and the rest of the world. "The hypothesis is that it has anti-inflammatory properties that may help prevent progression if treated early in the disease," said Oldenburg. "We did not find this to be the case."

The study, which was conducted in collaboration with Stanford University, appears July 16, 2021, in the Journal of the American Medical Association.

The study included 263 participants who all tested positive for SARS-CoV-2 within seven days before entering the study. None were hospitalized at the time of enrollment. In a random selection process, 171 participants received a single, 1.2 gram oral dose of azithromycin and 92 received an identical placebo.

At day 14 of the study, 50 percent of the participants remained symptom free in both groups. By day 21, five of the participants who received azithromycin had been hospitalized with severe symptoms of COVID-19 and none of the placebo group had been hospitalized.

The researchers concluded that treatment with a single dose of azithromycin compared to placebo did not result in greater likelihood of being symptom-free.

"Most of the trials done so far with azithromycin have focused on hospitalized patients with pretty severe disease," said Oldenburg. "Our paper is one of the first placebo-controlled studies showing no role for azithromycin in outpatients."

INFORMATION:

Co-authors included Jessica Brogdon, MPH&TM; Cindi Chen, MS; Kevin Ruder; Lina Zhong; Fanice Nyatigo; Catherine A. Cook, MPH; Armin Hinterwirth, PhD; Elodie Lebas, RN; Travis Redd, MD, MPH; Travis C. Porco, PhD, MPH; Thomas M. Lietman, MD; and Benjamin F. Arnold, PhD, MPH, all of UCSF; senior investigator Thuy Doan, MD, PhD, with the UCSF Proctor Foundation, and Benjamin A. Pinsky, MD, PhD, of Stanford University.

The trial was supported by the Bill and Melinda Gates Foundation (INV-017026). Azithromycin and matching placebo were donated by Pfizer, Inc. (New York, NY). Thuy Doan was supported in part by a Research to Prevent Blindness Career Development Award. The authors had no conflicts of interest.

About UCSF: The University of California, San Francisco (UCSF) is exclusively focused on the health sciences and is dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. UCSF Health, which serves as UCSF's primary academic medical center, includes top-ranked specialty hospitals and other clinical programs, and has affiliations throughout the Bay Area. UCSF School of Medicine also has a regional campus in Fresno. Learn more at END



ELSE PRESS RELEASES FROM THIS DATE:

Artificial sweeteners enable delivery of carbon monoxide to treat organ injury

2021-07-16
ATLANTA--An oral prodrug developed by a team of scientists led by Binghe Wang, Regents' Professor of Chemistry at Georgia State University, delivers carbon monoxide to protect against acute kidney injury, according to a new paper published in Chemical Science. Although carbon monoxide (CO) gas is toxic in large doses, scientists have discovered it can have beneficial effects by reducing inflammation and protecting cells against injury. Previous studies have demonstrated the protective effects of CO against injury in the kidneys, lungs, gastrointestinal tract and liver, among other organs. For the past five years, Wang and his collaborators have worked to design a safe way to deliver CO to human patients via prodrugs -- inactive compounds that ...

From birth control to mammograms, many women missed out on preventive care for all of 2020

2021-07-16
The COVID-19 pandemic knocked many women off schedule for important health appointments, a new study finds, and many didn't get back on schedule even after clinics reopened. The effect may have been greatest in areas where such care is already likely falling behind experts' recommendations. The study, by health care researchers in the University of Michigan END ...

Study examines the role of deep-sea microbial predators at hydrothermal vents

Study examines the role of deep-sea microbial predators at hydrothermal vents
2021-07-16
The hydrothermal vent fluids from the Gorda Ridge spreading center in the northeast Pacific Ocean create a biological hub of activity in the deep sea. There, in the dark ocean, a unique food web thrives not on photosynthesis but rather on chemical energy from the venting fluids. Among the creatures having a field day feasting at the Gorda Ridge vents is a diverse assortment of microbial eukaryotes, or protists, that graze on chemosynthetic bacteria and archaea. This protistan grazing, which is a key mechanism for carbon transport and recycling in microbial food webs, exerts a higher predation pressure at hydrothermal vent sites than in the surrounding deep-sea environment, a new paper finds. "Our ...

COVID-19 vaccination: Examining negative dominance on social media

2021-07-16
Vaccine negativity and reluctance didn't just emerge during the COVID-19 pandemic. In a recent study published in the Disaster Medicine and Public Health Preparedness journal, authors from Loyola University Maryland and Johns Hopkins Bloomberg School of Public Health explored the appearance of negative dominance - a concept in which negative messages outweigh positive, solution-oriented messages in audiences' perceptions - in the context of COVID-19 vaccine-related information and activity online. Prior research has looked at media coverage to identify vaccine concerns among the public and its impact on vaccine-related beliefs and behaviors, the spread of misinformation and fake news on the Internet, and the role ...

SUV39H2: A direct genetic link to autism spectrum disorders

SUV39H2: A direct genetic link to autism spectrum disorders
2021-07-16
New research from the RIKEN Center for Brain Science (CBS) in Japan shows that a deficit in histone methylation could lead to the development of autism spectrum disorders (ASD). A human variant of the SUV39H2 gene led researchers to examine its absence in mice. Published in Molecular Psychiatry, the study found that when absent, adult mice exhibited cognitive inflexibility similar to what occurs in autism, and embryonic mice showed misregulated expression of genes related to brain development. These findings represent the first direct link between the SUV39H2 gene and ASD. Genes are turned ...

Primary care payment model, telemedicine use for Medicare Advantage during pandemic

2021-07-16
What The Study Did: The association between primary care payment models and the use of telemedicine for Medicare Advantage enrollees during the COVID-19 pandemic was examined in this study. Authors: Brian W. Powers, M.D., M.B.A., of Humana Inc. in Louisville, Kentucky, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamahealthforum.2021.1597) Editor's Note: The article includes conflicts of interest disclosures. Please see the article for additional information, including other authors, author ...

Outcomes of patients treated by female vs male physicians

2021-07-16
What The Study Did: Researchers investigated whether death, other hospital outcomes and processes of care differed between patients cared for by female and male physicians at hospitals in Canada. Authors: Fahad Razak, M.D., M.Sc., of the University of Toronto in Ontario, Canada, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/  (doi:10.1001/jamahealthforum.2021.1615) Editor's Note: The article includes conflicts of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. #  #  # Media advisory: The full study is linked to this news ...

Exploring gap between excess mortality, COVID-19 deaths in 67 countries

2021-07-16
What The Study Did: National health care systems have different capacities to correctly identify people who died of COVID-19. Researchers in this study analyzed the gap between excess mortality and  COVID-19 confirmed mortality in 67 countries to determine the extent to which official data on COVID-19 deaths might be considered reliable. Authors: Davide Golinelli, M.D.,  Alma Mater Studiorum-University of Bologna in Italy, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2021.17359) Editor's ...

No sign of COVID-19 vaccine in breast milk

2021-07-16
Messenger RNA vaccines against COVID-19 were not detected in human milk, according to a small study by UC San Francisco, providing early evidence that the vaccine mRNA is not transferred to the infant. The study, which analyzed the breast milk of seven women after they received the mRNA vaccines and found no trace of the vaccine, offers the first direct data of vaccine safety during breastfeeding and could allay concerns among those who have declined vaccination or discontinued breastfeeding due to concern that vaccination might alter human milk. The paper appears in JAMA Pediatrics. Research has demonstrated that vaccines with mRNA inhibit transmission ...

New UK study reveals extent of brain complications in children hospitalized with COVID-19

2021-07-16
Although the risk of a child being admitted to hospital due to COVID-19 is small, a new UK study has found that around 1 in 20 of children hospitalised with COVID-19 develop brain or nerve complications linked to the viral infection. The research, published in The Lancet Child and Adolescent Health and led by the University of Liverpool, identifies a wide spectrum of neurological complications in children and suggests they may be more common than in adults admitted with COVID-19. While neurological problems have been reported in children with the newly described post-COVID condition paediatric inflammatory multisystem syndrome temporally ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Common COVID-19 antibiotic no more effective than placebo
UCSF outpatient study found limited effect of azithromycin on progression of disease